BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8820571)

  • 21. Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides.
    Redford TW; Yi AK; Ward CT; Krieg AM
    J Immunol; 1998 Oct; 161(8):3930-5. PubMed ID: 9780160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unmethylated CpG motifs protect murine B lymphocytes against Fas-mediated apoptosis.
    Wang Z; Karras JG; Colarusso TP; Foote LC; Rothstein TL
    Cell Immunol; 1997 Sep; 180(2):162-7. PubMed ID: 9341746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant properties of CpG oligonucleotides in primates.
    Verthelyi D
    Methods Mol Med; 2006; 127():139-58. PubMed ID: 16988453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemistry of CpG DNA.
    Kandimalla ER; Agrawal S
    Curr Protoc Nucleic Acid Chem; 2003 May; Chapter 4():Unit 4.16. PubMed ID: 18428906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmid DNA activates murine macrophages to induce inflammatory cytokines in a CpG motif-independent manner by complex formation with cationic liposomes.
    Yasuda K; Ogawa Y; Kishimoto M; Takagi T; Hashida M; Takakura Y
    Biochem Biophys Res Commun; 2002 Apr; 293(1):344-8. PubMed ID: 12054606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunostimulatory oligodeoxynucleotide isolated from genome wide screening of Mycobacterium bovis chromosomal DNA.
    Lee KW; Jung J; Lee Y; Kim TY; Choi SY; Park J; Kim DS; Kwon HJ
    Mol Immunol; 2006 May; 43(13):2107-18. PubMed ID: 16442622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
    Kandimalla ER; Bhagat L; Li Y; Yu D; Wang D; Cong YP; Song SS; Tang JX; Sullivan T; Agrawal S
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6925-30. PubMed ID: 15860583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of immunostimulatory CpG-DNA and its application to tuberculosis vaccine development.
    Yamamoto S; Yamamoto T; Nojima Y; Umemori K; Phalen S; McMurray DN; Kuramoto E; Iho S; Takauji R; Sato Y; Yamada T; Ohara N; Matsumoto S; Goto Y; Matsuo K; Tokunaga T
    Jpn J Infect Dis; 2002 Apr; 55(2):37-44. PubMed ID: 12082305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA and its cationic lipid complexes induce CpG motif-dependent activation of murine dendritic cells.
    Yoshinaga T; Yasuda K; Ogawa Y; Nishikawa M; Takakura Y
    Immunology; 2007 Mar; 120(3):295-302. PubMed ID: 17199803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice.
    Obermeier F; Dunger N; Deml L; Herfarth H; Schölmerich J; Falk W
    Eur J Immunol; 2002 Jul; 32(7):2084-92. PubMed ID: 12115630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of CpG DNA on HMGB1 release by murine macrophage cell lines.
    Jiang W; Li J; Gallowitsch-Puerta M; Tracey KJ; Pisetsky DS
    J Leukoc Biol; 2005 Oct; 78(4):930-6. PubMed ID: 16081598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy.
    Chaung HC
    Int Immunopharmacol; 2006 Oct; 6(10):1586-96. PubMed ID: 16919831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species.
    Yi AK; Tuetken R; Redford T; Waldschmidt M; Kirsch J; Krieg AM
    J Immunol; 1998 May; 160(10):4755-61. PubMed ID: 9590221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CpG-oligodeoxynucleotide protects immune cells from gamma-irradiation-induced cell death.
    Sohn WJ; Lee KW; Choi SY; Chung E; Lee Y; Kim TY; Lee SK; Choe YK; Lee JH; Kim DS; Kwon HJ
    Mol Immunol; 2006 Mar; 43(8):1163-71. PubMed ID: 16122803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA.
    Jakob T; Walker PS; Krieg AM; Udey MC; Vogel JC
    J Immunol; 1998 Sep; 161(6):3042-9. PubMed ID: 9743369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA.
    Krieg AM
    J Lab Clin Med; 1996 Aug; 128(2):128-33. PubMed ID: 8765208
    [No Abstract]   [Full Text] [Related]  

  • 37. The influence of base sequence on the immunostimulatory properties of DNA.
    Pisetsky DS
    Immunol Res; 1999; 19(1):35-46. PubMed ID: 10374694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CpG DNA rescues B cells from apoptosis by activating NFkappaB and preventing mitochondrial membrane potential disruption via a chloroquine-sensitive pathway.
    Yi AK; Peckham DW; Ashman RF; Krieg AM
    Int Immunol; 1999 Dec; 11(12):2015-24. PubMed ID: 10590267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CpG DNA: a pathogenic factor in systemic lupus erythematosus?
    Krieg AM
    J Clin Immunol; 1995 Nov; 15(6):284-92. PubMed ID: 8576314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Source of CpG Depletion in the HIV-1 Genome.
    Alinejad-Rokny H; Anwar F; Waters SA; Davenport MP; Ebrahimi D
    Mol Biol Evol; 2016 Dec; 33(12):3205-3212. PubMed ID: 27682824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.